By partnering with Siemens Healthcare Diagnostics, you can experience the assurance of an integrated hemostasis solution that can help improve both clinical and operational performance throughout your entire laboratory. Our INNOVANCE® line will help you gain efficiencies, increase operational workflow and throughput, and better manage your resources.
INNOVANCE DTI Assay
Our INNOVANCE DTI Assay* is an automated chromogenic testing solution for the quantitative determination of direct thrombin inhibitors in citrated human plasma. It delivers the high specificity and stability needed to confidently test for the direct oral anticoagulant dabigatran.
INNOVANCE Heparin Assay
Our INNOVANCE Heparin Assay* quantitatively determines the activity of unfractionated (UF) and low-molecular-weight (LMW) heparin in citrated plasma. Liquid reagents and a single hybrid calibration curve for UF and LMW heparin help deliver precise results in fewer steps.
Our INNOVANCE D-Dimer assay helps labs exclude deep vein thrombosis (DVT) and pulmonary embolism (PE) in conjunction with a non-high clinical pretest probability (PTP) asssesment model.
Our INNOVANCE Antithrombin assay provides better sensitivity for antithrombin type II defects.
INNOVANCE PFA P2Y
Our INNOVANCE PFA P2Y cartridge* reliably detects the blockade of P2Y12 receptors, i.e. Plavix® (Clopidogrel).
Our INNOVANCE ETP assay* is a new, innovative measure of global coagulability developed for routine clinical use.
INNOVANCE Free PS Ag
INNOVANCE Free PS Ag assay* provides a quantitative determination of protein S in human plasma based on state-of-the-art technology. The assay provides easy, highly specific and stable protein S antigen testing.
INNOVANCE VWF Ac
INNOVANCE VWF Ac assay* provides reliable, precise and senitive VWF determination. The significantly improved sensitivity ensures a convenient and economical VWF determination to optimize the labs VWF testing capability.